spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prou, D.
Right arrow Articles by Vernier, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prou, D.
Right arrow Articles by Vernier, P.
Journal of Cell Science 114, 3517-3527 (2001)
© 2001 The Company of Biologists Limited


RESEARCH ARTICLE

Intracellular retention of the two isoforms of the D2 dopamine receptor promotes endoplasmic reticulum disruption

Delphine Prou1,2,3,*, Wen-Jie Gu1,*, Stéphane Le Crom1, Jean-Didier Vincent1, Jean Salamero2 and Philippe Vernier1

1 DEPSN, UPR 2197, Institut de Neurobiologie Alfred Fessard, CNRS, Avenue de la Terrasse, F91198 Gif-sur-Yvette Cedex, France
2 UMR 144 CNRS Institut Curie, Laboratoire C Burg, 12 Rue Lhomond, 75005 Paris, France
3 Genaxis Biotechnology, Nîmes, France
* These authors contributed equally to this work

{ddagger}Author for correspondence (e-mail: vernier{at}iaf.cnrs-gif.fr)

Accepted June 26, 2001

The dopamine D2 receptor exists as a long (D2a) and a short (D2b) isoform generated by alternative splicing of the corresponding transcript, which modifies the length of the third cytoplasmic loop implicated in heterotrimeric G-protein-coupling. Anatomical data suggested that this segment regulates the intracellular traffic and localization of the receptor. To directly address this question we used a combination of tagging procedures and immunocytochemical techniques to detect each of the two D2 receptor isoforms. Surprisingly, most of the newly synthesized receptors accumulate in large intracellular compartments, the plasma membrane being only weakly labeled, without significant difference between the two receptor isoforms. Double labeling experiments showed that this localization corresponded neither to endosomal compartments nor to the Golgi apparatus. The D2 receptor is mostly retained in the endoplasmic reticulum (ER), the long isoform more efficiently than the short one. It is accompanied by a striking vacuolization of the ER, roughly proportional to the expression levels of the two receptor isoforms. This phenomenon is partly overcome by treatment with pertussis toxin. In addition, an intrinsic activity of the D2 receptor isoforms is revealed by [35S]-GTP{gamma}S binding and cAMP assay, which suggested that expression of weakly but constitutively active D2 receptors promotes activation of heterotrimeric G protein inside the secretory pathway. This mechanism may participate in the regulation of the cellular traffic of the D2 receptors isoforms.

Key words: Heterotrimeric G proteins, Cell compartments, Intrinsic activity




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
B. Rubi, S. Ljubicic, S. Pournourmohammadi, S. Carobbio, M. Armanet, C. Bartley, and P. Maechler
Dopamine D2-like Receptors Are Expressed in Pancreatic Beta Cells and Mediate Inhibition of Insulin Secretion
J. Biol. Chem., November 4, 2005; 280(44): 36824 - 36832.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. H. So, G. Varghese, K. J. Curley, M. M. C. Kong, M. Alijaniaram, X. Ji, T. Nguyen, B. F. O'Dowd, and S. R. George
D1 and D2 Dopamine Receptors Form Heterooligomers and Cointernalize after Selective Activation of Either Receptor
Mol. Pharmacol., September 1, 2005; 68(3): 568 - 578.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Kovoor, P. Seyffarth, J. Ebert, S. Barghshoon, C.-K. Chen, S. Schwarz, J. D. Axelrod, B. N. R. Cheyette, M. I. Simon, H. A. Lester, et al.
D2 Dopamine Receptors Colocalize Regulator of G-Protein Signaling 9-2 (RGS9-2) via the RGS9 DEP Domain, and RGS9 Knock-Out Mice Develop Dyskinesias Associated with Dopamine Pathways
J. Neurosci., February 23, 2005; 25(8): 2157 - 2165.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Mundschenk, N. Unger, S. Schulz, V. Hollt, S. Schulz, R. Steinke, and H. Lehnert
Somatostatin Receptor Subtypes in Human Pheochromocytoma: Subcellular Expression Pattern and Functional Relevance for Octreotide Scintigraphy
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5150 - 5157.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Chen, C. Wersinger, and A. Sidhu
Chronic Stimulation of D1 Dopamine Receptors in Human SK-N-MC Neuroblastoma Cells Induces Nitric-oxide Synthase Activation and Cytotoxicity
J. Biol. Chem., July 18, 2003; 278(30): 28089 - 28100.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 2001